人工智能心电图监测严重低钾血症患者血清钾动态变化
这项多中心回顾性队列研究纳入191例严重低钾血症成人患者,评估人工智能心电图(AI-ECG)在补钾治疗期间监测血清钾动态变化的表现。结果显示AI-ECG估算钾与实验室钾强相关(rmcorr 0.847),诊断准确度高(AUC 0.920),且比实验室结果平均早52.5分钟,在急性钾转移患者中相关性更高。
要点
- AI-ECG估算钾与实验室钾强相关,rmcorr为0.847,AUC为0.920。
- AI-ECG结果比实验室钾平均早52.5分钟,可实时监测钾变化。
- 急性钾转移患者的相关性高于慢性钾缺乏患者。
核心结论
- AI-ECG可在严重低钾血症治疗期间实时监测血清钾动态变化,在急性钾转移所致低钾血症中表现更优。
- AI-ECG作为无创辅助工具,可能缩短钾变化检测时间并减少实验室钾测量需求,但需验证性研究。
研究设计与样本
- 多中心回顾性队列研究,纳入3家教学医院2019年9月至2024年8月期间191例严重低钾血症成人患者(实验室钾≤2.5 mmol/L,匹配心电图钾<3.5 mmol/L),且补钾后24小时内有至少1次配对随访测量。
主要发现
- 191例患者中,156例(81.7%)为慢性钾缺乏,35例(18.3%)为急性钾转移。
- AI-ECG估算钾与实验室钾强相关(rmcorr 0.847 [95% CI, 0.81-0.88],P < 0.001),相关性受低钾血症病因影响(交互P < 0.0001),慢性钾缺乏患者相关性较低。
- AI-ECG诊断实验室钾<3.5 mmol/L的AUC为0.920(95% CI, 0.863-0.961),在急性钾转移患者中更高。
- AI-ECG结果比实验室钾平均早52.5分钟;急性钾转移患者纠正速度约为慢性钾缺乏患者的3倍(0.121 vs 0.039 mmol/L/h)。
- AI-ECG在2例患者中先于实验室确认检测到反弹性高钾血症。
临床怎么用
- AI-ECG可作为无创辅助工具,用于严重低钾血症治疗期间实时监测血钾变化,指导补钾并减少重复抽血。
- 在急性钾转移所致低钾血症中,AI-ECG监测性能更优,可优先考虑使用。
局限性
- 回顾性设计、治疗方案异质性、住院药物粒度有限以及潜在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Severe hypokalemia requires prompt management and close surveillance. Although artificial intelligence-enabled electrocardiography (AI-ECG) rapidly detects severe hypokalemia, its application for monitoring serum potassium (K+) dynamics during treatment remains unexplored. This study assessed AI-ECG performance in monitoring K+ changes during supplementation. STUDY DESIGN: Multicenter retrospective cohort study. SETTING & PARTICIPANTS: 191 adults with severe hypokalemia (laboratory-measured [lab-K+] ≤ 2.5 mmol/L; matched ECG-K+ < 3.5 mmol/L) and ≥1 follow-up paired measurement within 24 hours of K+ supplementation at 3 teaching hospitals between September 2019 and August 2024. EXPOSURE: Laboratory-measured K+ (lab-K+) and K+ estimated by ECG (ECG-K+) overall and stratified by the etiology of hypokalemia (acute K+ shift vs chronic K+ deficit). OUTCOME: Primary: agreement between paired ECG-K+ and lab-K+. Secondary: diagnostic accuracy and K+ trajectories. ANALYTICAL APPROACH: Linear mixed-effects models with patient-level random intercepts; repeated-measures correlation (rmcorr) and Bland-Altman plots; patient-level clustered bootstrapped receiver operating characteristic analysis for diagnostic accuracy. RESULTS: Of 191 patients, 156 (81.7%) had chronic K+ deficits (most commonly gastrointestinal disorders [n = 47] or diuretic use [n = 35]), and 35 (18.3%) had acute K+ shifts (most commonly thyrotoxic periodic paralysis [n = 25]). The chronic K+ deficits group had more comorbidities and use of medications affecting K+. ECG-K+ correlated strongly with lab-K+ (rmcorr 0.847 [95% CI, 0.81-0.88], P < 0.001). The relationship was modified by hypokalemia etiology (interaction P < 0.0001) with a lower correlation in patients with chronic K+ deficits. The diagnostic accuracy of ECG-K+ with lab-K+ < 3.5 mmol/L was reflected by an area under the curve of 0.920 (95% CI, 0.863-0.961). It was higher in patients with an acute K+ shift. ECG-K+ preceded lab-K+ results by a mean of 52.5 minutes. Patients with an acute K+ shift corrected approximately 3-fold faster than those with a chronic K+ deficit (0.121 vs 0.039 mmol/L/h). Rebound hyperkalemia was detected by ECG-K+ in 2 patients before laboratory confirmation. LIMITATIONS: Retrospective design, treatment-protocol heterogeneity, limited inpatient medication granularity, and potential selection bias. CONCLUSIONS: AI-ECG enables real-time, within-patient monitoring of serum K+ dynamics during treatment for severe hypokalemia, with superior performance in the setting of acute hypokalemia due to K+ shift. As a noninvasive adjunct, AI-ECG may shorten the time to detect changes in K+ and reduce the need for lab-K+ measurements rather than relying exclusively on lab-K+. Confirmatory studies are warranted. PLAIN-LANGUAGE SUMMARY: Severe hypokalemia, or very low blood potassium, is common in hospitalized patients and can cause dangerous heart rhythms. In clinical practice, potassium levels are often monitored with blood tests whose results are not immediately available. This study assessed whether an artificial intelligence (AI) tool that estimates blood potassium levels from a standard electrocardiogram (ECG) tracing can reduce the need for laboratory testing of blood for potassium levels. Patients with hypokalemia at 3 hospitals were studied. AI-based estimates of blood potassium were obtained very close in time to when blood was drawn for laboratory measurements of potassium. The AI-based estimates were available almost an hour earlier than laboratory tests, and both values were very similar. The similarity was greater when the hypokalemia was caused by a sudden shift into cells rather than chronic potassium loss from the body. AI-based estimates of potassium potentially offer a faster, noninvasive way to track potassium changes for patients over time, to guide potassium replacement, to reduce the need for repeated blood draws, and to detect dangerously high levels of potassium earlier.
引用
- Ding JJ, Lin C, Liao WI, et al. Artificial Intelligence-Enabled Electrocardiography for Monitoring Serum Potassium Dynamics in Patients With Severe Hypokalemia. Am J Kidney Dis. 2026. PMID: 42595038. doi:10.1053/j.ajkd.2026.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。